JNJ-26481585
≥98%
- Product Code: 101096
CAS:
875320-29-9
Molecular Weight: | 394.47 g./mol | Molecular Formula: | C₂₁H₂₆N₆O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD17010272 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
JNJ-26481585 is primarily investigated for its potential in cancer therapy, particularly as a histone deacetylase (HDAC) inhibitor. It is studied for its ability to induce apoptosis and inhibit the proliferation of cancer cells by modifying gene expression. This compound has shown promise in preclinical studies for treating various types of cancers, including hematological malignancies and solid tumors. Researchers are exploring its efficacy in combination with other anticancer agents to enhance therapeutic outcomes. Its role in epigenetic regulation makes it a valuable candidate for targeted cancer treatments.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿15,768.00 |
+
-
|
JNJ-26481585
JNJ-26481585 is primarily investigated for its potential in cancer therapy, particularly as a histone deacetylase (HDAC) inhibitor. It is studied for its ability to induce apoptosis and inhibit the proliferation of cancer cells by modifying gene expression. This compound has shown promise in preclinical studies for treating various types of cancers, including hematological malignancies and solid tumors. Researchers are exploring its efficacy in combination with other anticancer agents to enhance therapeutic outcomes. Its role in epigenetic regulation makes it a valuable candidate for targeted cancer treatments.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :